Update on Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA‐ALCL)

Update on Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA‐ALCL)

Women who are concerned about their breast implants following reports of a study linking infection caused by implants to a rare cancer, anaplastic large cell lymphoma (ALCL), should discuss their concerns with their doctor.

The Therapeutic Goods Authority continues not to recommend preventative breast implant removal in patients without symptoms or other abnormality.

ASPS is developing a national register of member surgeons who are willing to see concerned women with symptoms and assess their implants for no out-of-pocket expense consultation. The patients first option should be to see the surgeon who put the implants in but if they can’t or don’t want to, then members on the register will see the patient for an assessment with a referral from their GP.

This initial consultation is an opportunity to discuss concerns. If the patient chooses to undertake further investigation or commit to a procedure, subsequent costs may be incurred.

The register can be accessed here.


Media enquiries: Edwina Gatenby, mobile: 0402 130 254 or edwina@maxicom.net.au

Featured Stories

Position statement regarding breast reconstruction during the covid-19 pandemic – Victorian update August 2020

Recent publications have highlighted the considerable mortality rate for COVID-19…

Continue reading

10 October 2020

2020 ASAPS Aesthetic Breast Conference II – The Virtual Edition

Saturday, 10 October 2020 | 8.30am – 6.30pm AEDT In…

Register
Namrata Anavekar – Why Did You Want to Become a Plastic Surgeon?

See more

Further Information